Matthew M. Gosling, Senior VP, General Counsel at DEPOMED INC (DEPO), sold 8,819 shares at $15.85 ($140K) on 2014-12-02, disclosed to the SEC on 2014-12-03.
Scheduled sale ($140k) by Senior VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DEPO | SELL | 2017-05-15 | $1.3M | — | Filing → |
| DEPO | SELL | 2014-11-21 | $1.1M | — | Filing → |
| DEPO | SELL | 2014-03-14 | $322K | — | Filing → |